WaveMan · Form 4
Devers Shannon L. insider trades
> Search tickers & screens ⌘K
LIVE

Devers Shannon L. insider trades

Devers Shannon L. has filed 13 Form 4s with the SEC that we hold, all for Ionis Pharmaceuticals INC (IONS), as EVP, Chief Human Resources Ofc. Across all of them we count 0 purchases worth $0 and 16 sales worth $9.0M reported on Form 4. In the last 12 months: 0 purchases ($0) and 14 sales ($8.7M). The largest single trade was a sale of 25,545 shares of Ionis Pharmaceuticals INC worth $2.2M, dated 2026-01-07. The first filing on our record is dated 2024-10-01 and the latest 2026-04-02.

Ionis Pharmaceuticals INC (IONS)

EVP, Chief Human Resources Ofc · 13 filings · 16 purchases and sales
Trade dateCodeSharesValue as filedFiled
2025-01-16S, sale reported on Form 44,267$139.9K2025-01-17
2025-09-03S, sale reported on Form 43,162$192.9K2025-09-04
2025-10-15S, sale reported on Form 46,000$437.6K2025-10-16
2025-10-16S, sale reported on Form 41,263$93.0K2025-10-16
2025-11-25S, sale reported on Form 416,777$1.4M2025-11-28
2026-01-07S, sale reported on Form 425,545$2.2M2026-01-09
2026-01-07S, sale reported on Form 42,101$179.3K2026-01-09
2026-01-07S, sale reported on Form 49,264$783.9K2026-01-09
2026-01-07S, sale reported on Form 43,460$292.8K2026-01-09
2026-01-07S, sale reported on Form 43,829$324.0K2026-01-09
2026-01-16S, sale reported on Form 48,353$634.4K2026-01-20
2026-01-22S, sale reported on Form 43,977$323.5K2026-01-23
2026-03-03S, sale reported on Form 414,321$1.1M2026-03-05
2026-03-03S, sale reported on Form 45,030$402.4K2026-03-05
2026-03-03S, sale reported on Form 4755$61.0K2026-03-05
2026-04-02S, sale reported on Form 46,193$458.6K2026-04-02
Source

Counted from the Form 4 filings this reporting owner (SEC CIK 2037721) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.

Source: U.S. Securities and Exchange Commission (EDGAR) and other official government data · Updated 2026-10-12 · For informational purposes only, not investment advice.
Privacy · Terms